RECIST 1.0: Introduced in 2000, it provided the first standardized criteria for measuring tumor response. RECIST 1.1: Released in 2009, this version includes updates such as reducing the number of target lesions to a maximum of five and incorporating guidelines for assessing lymph nodes.
